Written evidence

Dr Sara Holland (Patent Attorney at Potter Clarkson) (ENB0055)

Constructive Bio (ENB0054)

UK Research and Innovation (UKRI) (ENB0053)

Institution of Chemical Engineers (IChemE) (ENB0052)

Dr Jim Ajioka (Chief Scientific Officer at Colorifix) (ENB0051)

Professor Paul Freemont (Co-Director at Innovation and Knowledge Centre for Synthetic Biology (SynbiCITE)) (ENB0050)

Prof. Yan Yan Shery Huang (Professor of Bioengineering at University of Cambridge) (ENB0049)

Health and Safety Executive (HSE) (ENB0048)

Royal Academy of Engineering (ENB0047)

Norwich Research Park (ENB0046)

Dr Martin Turner (Associate Director at UK BioIndustry Association) (ENB0045)

AstraZeneca (ENB0044)

Bristol BioDesign Institute, University of Bristol (ENB0043)

The Rosalind Franklin Institute (ENB0042)

Supergen Bioenergy Hub, and Biomass Biorefinery Network (ENB0041)

UK Agri-Tech Centre (ENB0040)

National Physical Laboratory (ENB0039)

UK Institute for Technical Skills and Strategy (ENB0038)

University of Edinburgh (ENB0037)

Paul Dalby (Professor in Biochemical Engineering and Biotechnology at University College London (UCL)), Gary Lye (Professor of Biochemical Engineering, Director of EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership, and Director UCL East Manufacturing Futures Lab at University College London (UCL)), Emily Kostas (UKRI Future Leaders Fellow at University College London (UCL)), and Chris Barnes (Professor of Systems and Synthetic Biology at University College London (UCL)) (ENB0036)